JPET # 83634

Introduction
The intracellular messenger guanosine 3'5'cyclic monophosphate (cGMP) and cGMP-dependent protein kinase (PKG) play a role in a wide variety of physiological responses including smooth muscle relaxation (Lincoln and Cornwell, 1993; Moro et al., 1996) .
The enzymes responsible for cGMP synthesis, the guanylyl cyclases (GCs), have been classically divided into two groups: soluble (sGC) and particulate (pGC) (Lucas et al., 2000) . sGC has been purified from the soluble fractions of various tissues (Garbers, 1979) , consistent with an entirely cytoplasmic localization, whereas pGC are integral membrane proteins (Chinkers et al., 1989) . According to the classical model, nitric oxide (NO) produced by the endothelial NO synthase (eNOS) is a short-lived gas that diffuses freely across cellular membranes to reach its receptor, the sGC (Moncada et al., 1991) whereas pGC is activated by natriuretic peptides (Chinkers et al., 1989) . eNOS has been shown to be localized to small invaginations of the plasma membrane called caveolae (Feron et al., 1996; Garcia-Cardena et al., 1996; Shaul et al., 1996) . Biochemically, caveolae represent a plasma membrane subdomain enriched with cholesterol, glycosphingolipids, and the structural proteins, caveolins that interact, in vitro, with a variety of signal-transducing molecules. Caveolin-1, a member of the protein caveolin family, is the major coat protein of caveolae (Anderson, 1998) .
eNOS catalyzes the production of NO in response to a rise in endothelial intracellular calcium concentration (Sanders et al., 2000) . The increase in the intracellular calcium promotes the dissociation of eNOS from the protein caveolin-1, necessary to its activation (Feron et al., 1996; Gratton et al., 2000) . This suggests that caveolae may function as a site of integration of events linking extracellular stimuli and (Galbiati et al., 1998; Voldstedlund et al., 2001 ). The absence of this organelle impairs NO and calcium signaling in the cardiovascular system, causing aberrations in endothelium-dependent relaxation, contractility, and maintenance of myogenic tone (Blair et al., 1999; Darblade et al., 2001; Je et al., 2004) .
Cholesterol depletion leads to a marked decline in Ach-induced eNOS activation and smooth muscle relaxation (Blair et al., 1999; Darblade et al., 2001) . Ach-induced relaxation in rat aorta is mainly attributed to NO (Shimokawa et al., 1996) . Colocalization of components in a signal transduction cascade appears to be a critical determinant of signaling efficiency by eNOS activation. It has been shown that NO is more soluble in a hydrophobic environment than in water (Goss et al., 1999) , making us to hypothesize that downstream molecules in the NO cascade must be in close relationship to the endothelial caveolae in the membrane.
The exciting possibility that caveolae provide a platform for interactions between eNOS activation and smooth muscle relaxation is emerging. This study tested the hypothesis that endothelial caveolae are the platform for sGC and PKG activation contributing to rat aortic smooth muscle relaxation. Because adenosine 3'5' cyclic monophosphate (cAMP)-dependent protein kinase (PKA) can also be activated by cGMP (Li et al., 2003) contributing to smooth muscle relaxation, localization of PKA to endothelial caveolae was also evaluated.
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Material and Methods
Animals
Male Sprague Dawley rats (200-224 g) maintained on a 12h light/dark cycle with rat chow and water ad libitum were anesthetized with sodium pentobarbital (50 mg/kg) and the thoracic aorta was excised. All experiments were conducted in accordance with the Medical College of Georgia's Animal Use for Research and Education Committee.
In Vitro Measurement of Isometric Force Generation in Aortic Rings
After removal of fat and connective tissue, aortic rings (4 mm long) were mounted in an organ chamber for isometric tension recordings and bathed in physiological salt solution (PSS) of the following composition in mmol/L: NaCl 130.0, KCl 4.7, KH 2 PO 4 1.2, MgSO 4 1.2, CaCl 2 1.6, NaHCO 3 14.9, EDTA 0.03, glucose 5.5 which was maintained at 37 o C and bubbled with 95% O 2 /5% CO 2 . Some of the experiments were performed in denuded aortas to avoid the interference of endothelial factors and endothelial caveolae.
The endothelium was mechanically removed by gently rubbing the intimal surface with stainless steel wires. The aortic rings were set at 3.5 -4.0 g passive tension. Under this tension, optimal contractile responses were previously observed in rat aorta. After a 1-hour equilibration period, vessels were contracted with phenylephrine (Sigma Chemicals, St Louis, MO, USA; 0.1 µmol/L) and subsequently treated with Ach (Sigma Chemicals, St Louis, MO, USA;10 µmol/L) to test tissue viability and the presence or Fluor 594 (Molecular Probes, final dilution 1:1000) were applied and incubated for 1 hour at room temperature. After washing in PBS, the slides were coverslipped with antifading mounting medium (Gel/Mount medium, Biomeda Corp., Foster City, CA, USA) and allowed to desiccate overnight at 4 C. Sections were viewed by confocal microscopy (Zeiss Confocal).
Electron microscopy
Endothelium-intact aortic segments treated with methyl-β-cyclodextrin ( 
Data Analysis
Sensitivity was expressed as pD 2 = -log EC 50 calculated by non-linear regression. Data were analyzed by Student's t-test for paired comparisons. Additional statistical analyses were performed using 1-way ANOVA followed by the Student-Newman-Keuls post hoc test for multiple comparisons. A value of P < 0.05 was considered statistically significant. 
Results
Effect of methyl-β-cyclodextrin on the relaxing response to acetylcholine
Ach induced concentration-dependent relaxation of phenylephrine-induced contraction (pD 2 = 6.06 ± 0.4, n=10) ( Fig. 1) . At a concentration of 1mmol/L, methyl-β-cyclodextrin (60 min) had no effect on Ach-induced relaxation (pD 2 = 6.6 ± 0.16, n=6, P > 0.05) ( Fig.   1 ) whereas prior exposure of tissues to 6 mmol/L methyl-β-cyclodextrin (60 min) inhibited the relaxation induced by 1 µmol/L of Ach (56.7 ± 6.4 %, n=10, control vs. 32.4 ± 7.3 %, n=4, after methyl-β-cyclodextrin, P < 0.05). Furthermore, 10 mmol/L methyl-β-cyclodextrin (60 min) inhibited Ach-induced relaxation to a greater extent and significantly decreased the maximal response to Ach (E max = 95.6 ± 5.4 %, n=10, control vs. 61.0 ± 9 %, n=6, after methyl-β-cyclodextrin, P < 0.01) (Fig. 1) .
Effect of methyl-β-cyclodextrin on the relaxing response to YC-1
The relaxation induced by YC-1 was inhibited in the presence of methyl-β-cyclodextrin (10 mmol/L, 60 min) in endothelium-intact and -denuded rat aortic rings (Fig. 2) . YC-1-induced relaxation in endothelium-intact (pD 2 = 6.6 ± 0.14, n=4) was significantly more inhibited in the presence of methyl-β-cyclodextrin (10 mmol/L, pD 2 = 5.31 ± 0.08, n=4, P < 0.001) ( Fig. 2A ) than in endothelium-denuded aortic rings (pD 2 = 5.8 ± 0.01, n=4, control vs. pD 2 = 5.3 ± 0.1, n=4, after methyl-β-cyclodextrin, P < 0.01) (Fig. 2B) . Methyl-β-cyclodextrin had no effect on nifedipine-induced relaxation (E max = 82.4 ± 4.7 %, pD 2 This article has not been copyedited and formatted. The final version may differ from this version. JPET # 83634 12 = 6.9 ± 0.5, n=6, control vs. E max = 81.0 ± 2.2 %, pD 2 = 7.0 ± 0.3, n=6, after methyl-β-cyclodextrin, P > 0.05).
Co-localization of caveolin-1 with sGC in rat aorta
Co-localization of caveolin-1 with sGC is shown by confocal-quality immunofluorescene microscopy in endothelium-intact and -denuded aortic sections (Fig. 3) . sGC was visualized using a red fluorescent secondary antibody (sGC), whereas caveolin-1 was visualized with a green fluorescent secondary antibody (Cav-1). A wide distribution of sGC and caveolin-1 was observed in endothelium-intact and -denuded aortic vessels.
Co-localization of the two proteins was confirmed by the overlay of pseudocolored red and green images, which results in a yellow signal at sites of co-localization. The yellow signal in the luminal part of the aorta was visualized in endothelium-intact but not in endothelium-denuded sections. The signal obtained by incubation with the red (Alexa Fluor 594) and green (Alexa Fluor 488) secondary antibodies alone representing tissue auto-fluorescence is also shown in Fig. 3 . Methyl-β-cyclodextrin prevented sGC and caveolin-1 co-localization in the endothelium (data not shown).
Effect of methyl-β-cyclodextrin on 8-Br-cGMP-induced relaxation
The sensitivity to 8-Br-cGMP was not changed in the presence of methyl-β-cyclodextrin (Fig. 4A) , whereas this inhibitory effect was not observed in endothelium-denuded aortic rings (Fig. 4B) .
Co-localization of caveolin-1 with PKG and PKA in rat aorta
Experiments were performed using primary antibodies against caveolin-1 and PKA or PKG in endothelium-intact and -denuded aorta. Double immunofluorescence was used to show co-localization of caveolin-1 with PKA and PKG in endothelium-intact anddenuded rat aortic sections by confocal-quality immunofluorescence microscopy (Fig. 5) .
PKG or PKA were visualized using the red fluorescent secondary antibody, whereas caveolin-1 was visualized with a green fluorescent secondary antibody (Cav-1). PKG, PKA and caveolin-1 are widely distributed in the endothelial and smooth muscle layers.
Sites of co-localization of caveolin-1 with PKG or PKA, represented by yellow, was observed in the smooth muscle layer and throughout most of the endothelium. Removal of the endothelium abolished co-localization of caveolin-1 with PKG ( Fig. 5 ) and PKA (data not shown). Methyl-β-cyclodextrin prevented the co-localization of these proteins in the endothelium (data not shown). 
Effects of methyl-β-cyclodextrin on endothelial caveolae
The effects of methyl-β-cyclodextrin (10 mmol/L) on the structure of aorta membrane were evaluated by transmission electron microscopy. Micrographs of endothelial cell membrane in control vessels (Fig. 6A) clearly show the presence of caveolae next to the apical plasma membrane that are rare or absent in samples treated methyl-β-cyclodextrin (Fig. 6B) . Cyclodextrin, a water-soluble cyclic oligosaccharide formed of seven glucopyranose units able to accept one molecule of cholesterol in its hydrophobic core, is a membrane impermeable molecule that depletes cellular cholesterol content through solubilization of the plasmalemal cholesterol (Kilsdonk et al., 1995) . This cholesterolbinding agent has been efficiently used as a pharmacological tool to study the role of caveolae in vascular reactivity (Dreja et al., 2002; Kaiser et al., 2002; Je et al., 2004) .
Indeed, in our experiments we observed by electron microscopy that endothelial caveolae were disassembled after exposure of aortic rings to methyl-β-cyclodextrin.
Some agonists causing contraction of vascular smooth muscle act on receptors that are believed to be located in caveolae or to aggregate in caveolae upon ligand We observed that the relaxation induced by Ach is impaired after treatment with methyl-β-cyclodextrin, suggesting localization of eNOS in rat aorta endothelial caveolae.
Similar results were reported in rabbit aorta (Darblade et al., 2001 ) whereas in guinea pig aorta, treatment with methyl-β-cyclodextrin abolished the relaxation induced by Ach (Kaiser et al, 2002) . It has been reported that caveolar cholesterol depletion is associated with a marked decline in Ach-induced eNOS activation (Blair et al., 1999) . As far as protein composition, caveolae are characterized by the presence of a family of three proteins called caveolins. Caveolin-1 is surely the most important protein involved in the structure and function of caveolae (Anderson, 1998) . eNOS is regulated by caveolin-1. By its interaction with caveolin-1, eNOS is maintained in an inactive state Garcia-Cardena et al., 1996; Ju et al., 1997) . Upon stimulation followed by an increase in intracellular calcium concentration, eNOS dissociates from caveolin-1, a necessary step for its activation and NO production (Feron et al., 1996; Gratton et al., 2000) .
Caveolae are therefore regulatory platforms for the cascade of events resulting in NO production.
Although the natural receptor for NO, the sGC has been detected in association with the plasma membrane (Zabel et al., 2002; Venema et al., 2003) and sGC is translocated to caveolar domains to be sensitized by NO (Zabel et al., 2002) , the interaction with caveolin-1 and the role of this association with the plasma membrane in blood vessel relaxation are unknown. We observed that the relaxation induced by the sGC activator YC-1 is impaired in the presence of methyl-β-cyclodextrin in rat aorta.
However, methyl-β-cyclodextrin had no effect on the relaxation induced by nifedipine indicating that a cGMP-independent relaxing pathway is not altered by methyl-β-cyclodextrin. We also observed co-localization of caveolin-1 with sGC in aorta endothelium that was abolished in the presence of methyl-β-cyclodextrin. Caveolar association of sGC has been reported to be sensitive to detergent (Zabel et al., 2002) , indicating that this membrane association is labile. It is interesting to note that we did not make use of detergents in our procedures, supporting the concept that the site of colocalization is the membrane. These findings established the compartmentalization of sGC to caveolae due to its association with caveolin-1 in the endothelium introducing a potential therapeutic strategy for cardiovascular diseases related to endothelial dysfunction. We also observed that the relaxation induced by 8-Br-cGMP is impaired in endothelium-intact aortic rings previously treated with methyl-β-cyclodextrin. The differences between the inhibition by methyl-β-cyclodextrin to YC-1-and 8-Br-cGMPinduced relaxation may be related to the additional effects attributed to YC-1. YC-1 has been shown to not only activate sGC, but also to potentiate the stimulatory action of NO (Friebe and Koesling, 1998; Schmidt et al., 2001) . YC-1 also affects cGMP metabolism inhibiting cGMP breakdown and the activity of phosphodiesterase (Galle et al., 1999) and it stimulates NO synthesis and release in endothelial cells independently of elevation in cGMP levels (Wohlfart et al., 1999) .
cGMP generated upon sGC activation in the microdomain underlying endothelial caveolae may activate PKG. Indeed, we observed co-localization of caveolin-1 and PKG in rat aorta endothelium. Cross-talk between cGMP and adenosine 3'5' cyclic monophosphate (cAMP) has been reported (Dhanakoti et al., 2000; White et al., 2000) . cGMP can also activate cAMP-dependent protein kinase (PKA) (Li et al., 2003) .
It was recently reported that membrane cholesterol content regulates PKA activity (Burgos et al., 2004) and that the catalytic subunit of PKA was associated with cell surface caveolae (Heijnen et al., 2004) . In our study, we observed co-localization of caveolin-1 and PKA in rat aortic endothelium prevented after cholesterol depletion with methyl-β-cyclodextrin. Kaufmann et al., 2003; Schafer et al., 2003) . Of the known phosphorylation sites on eNOS responsible for its activation, serine 1179 has been characterized most extensively (Chen et al., 1999; Fulton et al., 2002) . Serine 1179 phosphorylation by PKA leads to activation of eNOS (Butt et al., 2000) . We hypothesize that the mechanisms by which NO-cGMP-PKA pathway in the endothelium mediates vascular smooth muscle relaxation involve NO production through eNOS phosphorylation by PKA. The role of the association of PKG with caveolin-1 in rat aortic endothelial caveolae remains unclear and requires further investigation.
In summary, we propose that sGC and PKA are compartmentalized in endothelial caveolae as a necessary spatial organization to facilitate NO actions. Our results provide new insights by which the endothelium mediates vascular smooth muscle relaxation.
